a public good project by the
Synthesis
Company
of California

© 2026

Guoqiang Dong | doi.page

0 works0 citations0 h-index

Guoqiang Dong

Guangxi University(CN)Second Military Medical University(CN)

Publications by Year

Research Areas

Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, Cancer therapeutics and mechanisms, Ubiquitin and proteasome pathways, Synthesis and Biological Evaluation

Most-Cited Works

→ Molecular Glues for Targeted Protein Degradation: From Serendipity to Rational Discovery(2021)321 cited
→ Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer(2021)265 cited
→ Structural Simplification of Natural Products(2019)239 cited
→ Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents(2015)192 cited
→ New Tricks for an Old Natural Product: Discovery of Highly Potent Evodiamine Derivatives as Novel Antitumor Agents by Systemic Structure–Activity Relationship Analysis and Biological Evaluations(2012)181 cited
→ State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors(2015)157 cited

→ Potent Dual BET/HDAC Inhibitors for Efficient Treatment of Pancreatic Cancer(2020)

148 cited

→ Selection of Evodiamine as a Novel Topoisomerase I Inhibitor by Structure-Based Virtual Screening and Hit Optimization of Evodiamine Derivatives as Antitumor Agents(2010)147 cited

→ Fulvic acid ameliorates drought stress-induced damage in tea plants by regulating the ascorbate metabolism and flavonoids biosynthesis(2020)130 cited

→ Discovery, Synthesis, and Biological Evaluation of Orally Active Pyrrolidone Derivatives as Novel Inhibitors of p53–MDM2 Protein–Protein Interaction(2012)129 cited